Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart M Robinson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Scientific Reports|May 16, 2019
Systemic inflammation contributes to impairment of quality of life in chronic pancreatitisStuart M Robinson, Sebastian Rasch, Sebastian Beer, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 6, 2013
N-acetylcysteine administration does not improve patient outcome after liver resectionStuart M Robinson, Rehan Saif, Gourab Sen, et al.
Clinical Epigenetics|April 11, 2015
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver diseaseMüjdat Zeybel, Timothy Hardy, Stuart M Robinson, et al.
Pancreas|October 30, 2020
Therapeutic Strategies Toward Lactate Dehydrogenase Within the Tumor Microenvironment of Pancreatic CancerJohn A G Moir, Anna Long, Beate Haugk, et al.
Endocrine-Related Cancer|June 2, 2017
Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasmsRoberto Valente, Alastair J Hayes, Sven-Petter Haugvik, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 10, 2017
Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional studyVille J Sallinen, Tessa Y S Le Large, Elke Tieftrunk, et al.
The FEBS Journal|March 14, 2025
Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitorsMaria Teresa Borrello, Dusan Ruzic, Hannah Paish, et al.
Metabolism: Clinical and Experimental|March 24, 2025
Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liverAleksandra Gruevska, Jack Leslie, Elena Perpiñán, et al.
Gut|April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosisMarina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.
Hepatology (Baltimore, Md.)|April 10, 2019
A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver SlicesHannah L Paish, Lee H Reed, Helen Brown, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Scientific Reports|May 16, 2019
Systemic inflammation contributes to impairment of quality of life in chronic pancreatitisStuart M Robinson, Sebastian Rasch, Sebastian Beer, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 6, 2013
N-acetylcysteine administration does not improve patient outcome after liver resectionStuart M Robinson, Rehan Saif, Gourab Sen, et al.
Clinical Epigenetics|April 11, 2015
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver diseaseMüjdat Zeybel, Timothy Hardy, Stuart M Robinson, et al.
Pancreas|October 30, 2020
Therapeutic Strategies Toward Lactate Dehydrogenase Within the Tumor Microenvironment of Pancreatic CancerJohn A G Moir, Anna Long, Beate Haugk, et al.
Endocrine-Related Cancer|June 2, 2017
Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasmsRoberto Valente, Alastair J Hayes, Sven-Petter Haugvik, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 10, 2017
Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional studyVille J Sallinen, Tessa Y S Le Large, Elke Tieftrunk, et al.
The FEBS Journal|March 14, 2025
Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitorsMaria Teresa Borrello, Dusan Ruzic, Hannah Paish, et al.
Metabolism: Clinical and Experimental|March 24, 2025
Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liverAleksandra Gruevska, Jack Leslie, Elena Perpiñán, et al.
Gut|April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosisMarina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.
Hepatology (Baltimore, Md.)|April 10, 2019
A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver SlicesHannah L Paish, Lee H Reed, Helen Brown, et al.
Pageof 3